Toronto Innovation Acceleration Partners – TIAP – specializes in venture building of
early-stage health science technologies emerging from our members.
TIAP was formerly MaRS Innovation
Our Members
TIAP’s portfolio draws from the University of Toronto, seven teaching hospitals and two research institutes. Learn more about our members.Learn More›
Work With Us
Through our member-exclusive funding programs and services, TIAP works with founders to bring their health science technologies to market faster.Learn More›
Recent News
FedDev Ontario Funding Support – Portfolio Investments
On October 9, 2020, the Honourable Mélanie Joly, then Minister of Economic Development and Official Languages and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) announced a FedDev …
Highly Positive Results from PoC Phase 1b trial of ZT-01 – Type 1 Diabetes
Zucara Therapeutics announced highly positive results from its proof-of-concept Phase 1b trial of ZT-01 in people with Type 1 diabetes (“T1D”). Please see the press release here. Why this news is important:
This trial confirms ZT-01’s mechanism of action in restoring …
Phenotips Raises $2.5M in First Round of Financing
Our startup company, Phenotips (formerly Gene42), announced in September, 2021, that it raised C$2.5M in its first round of financing. TIAP was an early investor and most recently, in this round, participated with additional …
Roadmap for an Integrated Life Sciences Ecosystem In Ontario
LSO – Life Sciences Ontario – prepared an in-depth and informative report on the importance of the life science sector in Ontario. TIAP was one of the endorsing organizations. The report was published in …